Bayesian Glaciological Modelling to quantify uncertainties in ice core chronologies

first_imgValuable information about the environment and climate of the past is preserved in ice cores which are drilled through ice sheets in polar and alpine regions. A pivotal part of interpreting the information held within the cores is to build ice core chronologies i.e. to relate time to depth. Existing dating methods can be categorised as follows: (1) layer counting using the seasonality in signals, (2) glaciological modelling describing processes such as snow accumulation and plastic deformation of ice, (3) comparison with other dated records, or (4) any combination of these. Conventionally, implementation of these approaches does not use statistical methods. In order to quantify dating uncertainties, in this paper we develop the approach of category (2) further. First, the sources of uncertainty involved in glaciological models are formalised. Feeding these into a statistical framework, that we call Bayesian Glaciological Modelling (BGM), allows us to demonstrate the effect that uncertainty in the glaciological model has on the chronology. BGM may also include additional information to constrain the resulting chronology, for example from layer counting or other dated records such as traces from volcanic eruptions.Our case study involves applying BGM to date an Antarctic ice core (a Dyer plateau core). Working through this example allows us to emphasise the importance of properly assessing uncertain elements in order to arrive at accurate chronologies, including valid dating uncertainties. Valid dating uncertainties, in turn, facilitate the interpretation of environmental and climatic conditions at the location of the ice core as well as the comparison and development of ice core chronologies from different locations.last_img read more

Equinor awards study contracts for Wisting discovery offshore Norway

first_imgLocated in the Hoop area of the Barents Sea, the Wisting license is estimated to have 440 million barrels of oil equivalent Equinor is the operator of the Wisting license. (Credit: Equinor ASA) Norwegian firm Equinor, on behalf of the Wisting oilfield licence partners, has awarded concept studies contracts for the development of the Wisting discovery in the Barents Sea offshore Norway.Located in the Hoop area of the Barents Sea, around 310km from the Norwegian mainland, the Wisting license is estimated to have 440 million barrels of oil equivalent.Equinor project development acting senior vice-president Trond Bokn said that the Wisting is a considerable oil field in the Barents Sea.“Founded on experience and synergy potential within the project-portfolio we have assessed different development alternatives to identify potential solutions for a cost-effective and optimal field development.“Based on this work, the licence partners have decided to further assess a floating production unit based on a circular FPSO solution (floating production, storage and offloading). However, a lot of work remains before we can make a final concept select during second quarter of 2021.”FPSO concept study awarded to Aker, KBR, Sevan SSP and AibelFor the floating production storage and offloading (FPSO) concept study, Equinor has awarded the contracts to Aker Solutions, KBR, Sevan SSP and Aibel.Aker Solutions, TechnipFMC, OneSubsea Processing, IKM Ocean Design, and Kongsberg Maritime have been selected for subsea production and processing equipment, umbilical, risers and flowlines (SURF) study for the Wisting discovery.Last year, Equinor has assumed the operatorship of the Wisting licence from Austrian firm OMV. This follows the signing of a memorandum of understanding (MoU) signed between the firms in June 2019 for collaboration on the Wisting development.Under the MoU, Equinor agreed to assume the role of the operator of Wisting in the development phase, while OMV will assume the role as the operator in the operating phase.Bokn said: “Electrification is considered a possible option for reducing field emissions. The project will study a power-from-shore solution for a circular FPSO going forward.”Equinor operates the Wisting licence with 35% stake while other partners include OMV (Norge) (25%), Petoro (20%) and Idemitsu Petroleum Norge (20%).The final investment decision for the Wisting project is scheduled at the end of 2022.last_img read more

France: BPC Dixmude Comes to Toulon for Combat System Integration, Testing

first_imgBack to overview,Home naval-today France: BPC Dixmude Comes to Toulon for Combat System Integration, Testing View post tag: Toulon View post tag: France View post tag: Naval View post tag: News by topic View post tag: BPC View post tag: Dixmude France: BPC Dixmude Comes to Toulon for Combat System Integration, Testing BPC Dixmude – the third Mistral/BPC-type force projection & command vessel for the French Navy – arrived in Toulon after sailing from Saint-Nazaire on 6 July. Over the coming six months, DCNS will settle the ship’s combat system. The ship will be delivered to the French defence procurement agency DGA in early 2012.DGA ordered BPC Dixmude in April 2009 as part of an economic stimulus package proposed by French President Nicolas Sarkozy. The resulting industrial cooperation programme was awarded to DCNS and STX France and the platform built at the STX France shipyard in Saint-Nazaire in cooperation with DCNS.Over the coming six months, DCNS will settle the combat system which includes the communications, navigation and combat management systems. Successful integration hinges on value-adding expertise every step of the way. The work will be performed by teams of experts – about 100 people in all – provided by DCNS and its partners. These are vital to operational missions and represent around one-quarter of the ship’s total value.BPC Dixmude is scheduled for delivery to the DGA in early 2012 and for entry into active service later in the year. BPC Mistral and BPC Tonnerre, the first two Mistral-class force projection & command vessels, were built by DCNS and the then-Chantiers de l’Atlantique and delivered to the Navy in 2006 and 2007 respectively.On 17 June, DCNS signed a contract with Russian defence export agency Rosoboronexport for the supply of two Mistral/BPC-type vessels and associated services including initial logistics, training, and technology transfers. This is the first export success for the Mistral/BPC design. On the international market, the type is known as a landing helicopter dock or LHD. The first ship will be delivered to Russia in 2014, just three years after the contract go-ahead. The second will be delivered in 2015.With a length of 199 metres, a displacement of 21,500 tonnes and a speed of 19 knots, BPCs offer a global projection capability for troops and materiel including 450 troops and 16 heavy helicopters plus one of several options: two hovercraft, two new-generation EDA-R high-speed landing craft, four LCM-type landing craft or one-third of a mechanised regiment complete with armoured vehicles (representing a payload of 1,000 tonnes). BPCs also offer ample capacity as hospital ships or for large-scale humanitarian missions. The design features electric propulsion using azimuth pods and high-level automation compatible with a complement of just 170. A high-performance communications suite, a 3D surveillance radar and a Senit 9 combat management system (CMS) make the type ideal as a naval force command vessel.[mappress]Source:dcnsgroup, July 15, 2011; Equipment & technologycenter_img View post tag: comes View post tag: Integration July 15, 2011 View post tag: system View post tag: Navy View post tag: testing View post tag: Combat Share this articlelast_img read more

EU NAVFOR Welcomes German MPRA

first_img View post tag: EU Share this article View post tag: German Back to overview,Home naval-today EU NAVFOR Welcomes German MPRA EU NAVFOR welcomed a German Maritime Patrol Reconnaissance Aircraft (MPRA) which will operate off the Horn of Africa. Based in Djibouti, the Lockheed Martin P-3C ‘ORION’, will add to the mission’s capabilities until December.In a letter to the detachment, the Force Commander, Rear Admiral Thomas Jugel, welcomed the soldiers: “Let me heartily welcome the German P-3C ORION Detachment and all its men and women in Operation ATALANTA. Let’s work together!”The operational area off the Horn of Africa is as large as Europe. The ‘ORION’, as a “flying eye”, is fitted with modern sensor technology. With its radar the MPRA is able to give the warships a current picture of surface contacts in the area of operation and it is a significant contribution to fighting piracy and securing the shipping lanes off the Horn of Africa.“As we all know, Maritime Patrol Reconnaissance Aircraft provide an indispensable supplement to our intelligence and reconnaissance capability. And reliable intelligence is prerequisite for successful counter piracy operations. Keeping this in mind, the German aircraft joins exactly at the right time. This reinforcement is urgently needed because we will see a strong pirate surge during the upcoming inter monsoon phase”, said Rear Admiral Thomas Jugel.–EU NAVFOR Somalia is a counter-piracy taskforce operating in the area of the Gulf of Aden and the Indian Ocean responsible for deterring, preventing and repressing acts of piracy, for the safe escort of ships carrying humanitarian aid of the World Food Program and vessels of African Union Mission in Somalia (AMISOM) and to protect other vulnerable vessels. Additionally, EU NAVFOR also monitors fishing activity off the coast of Somalia[mappress]Source: eunavfor, September 27, 2011 September 27, 2011center_img View post tag: MPRA View post tag: NAVFOR View post tag: welcomes EU NAVFOR Welcomes German MPRAlast_img read more

Boeing Delivers Another P-8I to Indian Navy

first_img Boeing Delivers Another P-8I to Indian Navy View post tag: News by topic View post tag: asia Back to overview,Home naval-today Boeing Delivers Another P-8I to Indian Navy View post tag: Boeing Boeing has delivered the fourth P-8I maritime patrol aircraft to the Indian Navy on schedule, fulfilling the first half of a contract for eight aircraft. View post tag: P-8I View post tag: Indian Navy View post tag: Navycenter_img Share this article May 28, 2014 The aircraft departed from Boeing Field in Seattle and arrived May 21 at Naval Air Station Rajali, where it joined three P-8Is currently undergoing operational evaluation.“This marks an important milestone – the halfway point for P-8I deliveries to India,” said Dennis Swanson, BDS vice president in India. “The program’s success the past year is really a testament to the great work between Boeing, the Indian Navy and industry.”Based on the company’s Next-Generation 737 commercial airplane, the P-8I is the Indian Navy variant of the P-8A Poseidon that Boeing has developed for the U.S. Navy.“The Indian Navy is putting the first three P-8Is through their paces operationally, and the P-8I delivered today will begin flight trials in the coming months,” said Leland Wight, Boeing P-8I program manager.The P-8I incorporates not only India-unique design features, but also India-built subsystems that are tailored to the country’s maritime patrol requirements. In order to efficiently design and build the P-8I and the P-8A, the Boeing-led team is using a first-in-industry, in-line production process that draws on the company’s Next-Generation 737 production system.The P-8I features open system architecture, advanced sensor and display technologies, and a worldwide base of suppliers, parts and support equipment. P-8I aircraft are built by a Boeing-led industry team that includes CFM International, Northrop Grumman, Raytheon, Spirit AeroSystems, BAE Systems and GE Aviation.[mappress]Press Release, May 28, 2014; Image: Boeing Authorities View post tag: ANOTHER View post tag: Naval View post tag: deliverslast_img read more

Mayor’s Message: Police Preparing for Possible Protest Tuesday

first_imgMayor Jay Gillian Dear Friends,The Ocean City Police Department has received information that a protest is being planned for Tuesday as part of the “Black Lives Matter” movement.Police are investigating further, coordinating with several other agencies and preparing for any potential situation.As we receive additional information, we will inform the public.Warm regards,Mayor Jay A. Gillianlast_img

Food in the news

first_imgThe GM debate reared its head in The Telegraph around calls to rebrand GM. “We need a new language. Perhaps vaccination or inoculation is less scary for the public,” said Bill Clark, who runs Broom’s Barn Research Centre, part of agricultural research centre Rothamsted Research. He argued that changing the public perception of GM was essential if the poor wheat yields in Britain and Europe were to be overcome. “Wheat yields have plateaued over the last 15 years,” he said. Peter Melchett, policy director at the Soil Association, branded the comments “desperate rubbish”.Food sales growth slowed in December as snow disrupted sales patterns and trade was lost, according to the British Retail Consortium. However, non-food had a much tougher time, it said.Families are to benefit from £50 voucher books to help them to eat more healthily and be more active, as the next phase of the Government’s Change4Life programme is announced. Families will be encouraged to swap one unhealthy habit for a healthier one, and will have access to vouchers for money-off healthier foods, including a Warburtons Wholemeal loaf and activities.last_img read more

Coronavirus has come to Michiana: Here’s what you need to know

first_img Facebook Coronavirus has come to Michiana: Here’s what you need to know By Tommie Lee – March 11, 2020 1 1038 If you are a healthcare provider or a public health responder caring for a COVID-19 patient, please take care of yourself and follow recommended infection control procedures.If you are a close contact of someone with COVID-19 and develop symptoms of COVID-19, call your healthcare provider and tell them about your symptoms and your exposure. They will decide whether you need to be tested, but keep in mind that there is no treatment for COVID-19 and people who are mildly ill are able to isolate at home.If you are a resident in a community where there is ongoing spread of COVID-19 and you develop COVID-19 symptoms, call your healthcare provider and tell them about your symptoms. They will decide whether you need to be tested, but keep in mind that there is no treatment for COVID-19 and people who are mildly ill are able to isolate at home. Twitter Pinterest WhatsApp (photo/CDC) The first positive test for coronavirus in Michiana was identified in St. Joseph County on Wednesday, March 11th.The virus was found in a male patient in his 50s who has quarantined at home and was said to have been tested away from other patients.County health officials are echoing the advice of CDC officials and suggesting people follow common sense health practices, as well as avoiding public gatherings.The latest information from the CDC: https://www.cdc.gov/coronavirus/2019-ncov/summary.htmlFrom The State of Indiana: https://www.in.gov/isdh/28470.htmFrom The State of Michigan: https://www.michigan.gov/CoronavirusFrom The South Bend Community School Corporation: http://sb.school/cms/One.aspx?portalId=68976&pageId=23551606From The University of Notre Dame: https://coronavirus.nd.edu/From Indiana University: https://coronavirus.iu.edu/index.htmlFrom Purdue University: https://www.purdue.edu/newsroom/releases/2020/Q1/need-to-know-info-about-covid-2019.html_______________________________________Coronavirus information from the Centers for Disease Control and Prevention:Background CDC has deployed multidisciplinary teams to support state health departments case identification, contact tracing, clinical management, and public communications.CDC has worked with federal partners to support the safe return of Americans overseas who have been affected by COVID-19. CDC is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus that was first detected in China and which has now been detected in more than 100 locations internationally, including in the United States. The virus has been named “SARS-CoV-2” and the disease it causes has been named “coronavirus disease 2019” (abbreviated “COVID-19”).On January 30, 2020, the International Health Regulations Emergency Committee of the World Health Organization declared the outbreak a “public health emergency of international concernexternal icon” (PHEIC). On January 31, 2020, Health and Human Services Secretary Alex M. Azar II declared a public health emergency (PHE) for the United States to aid the nation’s healthcare community in responding to COVID-19. On March 11, 2020 WHO publiclyexternal icon characterized COVID-19 as a pandemic.Source and Spread of the VirusCoronaviruses are a large family of viruses that are common in people and many different species of animals, including camels, cattle, cats, and bats. Rarely, animal coronaviruses can infect people and then spread between people such as with MERS-CoV, SARS-CoV, and now with this new virus (named SARS-CoV-2).The SARS-CoV-2 virus is a betacoronavirus, like MERS-CoV and SARS-CoV.  All three of these viruses have their origins in bats. The sequences from U.S. patients are similar to the one that China initially posted, suggesting a likely single, recent emergence of this virus from an animal reservoir.Early on, many of the patients at the epicenter of the outbreak in Wuhan, Hubei Province, China had some link to a large seafood and live animal market, suggesting animal-to-person spread. Later, a growing number of patients reportedly did not have exposure to animal markets, indicating person-to-person spread. Person-to-person spread was subsequently reported outside Hubei and in countries outside China, including in the United States. Some international destinations now have apparent community spread with the virus that causes COVID-19, as do some parts of the United States. Community spread means some people have been infected and it is not known how or where they became exposed. Learn what is known about the spread of this newly emerged coronaviruses. An important part of CDC’s role during a public health emergency is to develop a test for the pathogen and equip state and local public health labs with testing capacity.CDC developed an rRT-PCR test to diagnose COVID-19.As of the evening of March 8, 78 state and local public health labs in 50 states and the District of Columbia have successfully verified and are currently using COVID-19 diagnostic tests.Combined with other reagents that CDC has procured, there are enough testing kits to test more than 75,000 people.In addition, CDC has two laboratories conducting testing for the virus that causes COVID-19. CDC can test approximately 350 specimens per day.Commercial labs are working to develop their own tests that hopefully will be available soon. This will allow a greater number of tests to happen close to where potential cases are. CDC has grown the COVID-19 virus in cell culture, which is necessary for further studies, including for additional genetic characterization. The cell-grown virus was sent to NIH’s BEI Resources Repositoryexternal icon for use by the broad scientific community.CDC also is developing a serology test for COVID-19.CDC RecommendsEveryone can do their part to help us respond to this emerging public health threat:Individuals and communities should familiarize themselves with recommendations to protect themselves and their communities from getting and spreading respiratory illnesses like COVID-19.Older people and people with severe chronic conditions should take special precautions because they are at higher risk of developing serious COVID-19 illness.If you are a healthcare provider, be on the look-out for:People who recently traveled from China or another affected area and who have symptoms associated with COVID-19, andPeople who have been in close contact with someone with COVID-19 or patients with pneumonia of unknown cause. (Consult the most recent definition for patients under investigation [PUIs].) Pinterest Situation in U.S.In addition to CDC, many public health laboratories are now testing for the virus that causes COVID-19. View CDC’s Public Health Laboratory Testing map.With this increase in testing, more and more states are reporting cases of COVID-19 to CDC. View latest case counts, deaths, and a map of states with reported cases.U.S. COVID-19 cases include:Imported cases in travelersCases among close contacts of a known caseCommunity-acquired cases where the source of the infection is unknown. Confirmed COVID-19 Cases Global Mapcenter_img CDC has issued clinical guidance, including:On January 30, CDC published guidance for healthcare professionals on the clinical care of  COVID-19 patients.On February 3, CDC posted guidance for assessing the potential risk for various exposures to COVID-19 and managing those people appropriately.On February 27, CDC updated its criteria to guide evaluation of persons under investigation for COVID-19.On March 8, CDC issued a Health Alert Network (HAN). COVID-19 cases in the U.S. This is a picture of CDC’s laboratory test kit for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). CDC tests are provided to U.S. state and local public health laboratories, Department of Defense (DOD) laboratories and select international laboratories. Illness SeverityThe complete clinical picture with regard to COVID-19 is not fully known. Reported illnesses have ranged from very mild (including some with no reported symptoms) to severe, including illness resulting in death. While information so far suggests that most COVID-19 illness is mild, a reportexternal icon out of China suggests serious illness occurs in 16% of cases. Older people and people of all ages with severe underlying health conditions — like heart disease, lung disease and diabetes, for example — seem to be at higher risk of developing serious COVID-19 illness.Learn more about the symptoms associated with COVID-19.There are ongoing investigations to learn more. This is a rapidly evolving situation and information will be updated as it becomes available.Risk AssessmentOutbreaks of novel virus infections among people are always of public health concern. The risk to the general public from these outbreaks depends on characteristics of the virus, including how well it spreads between people; the severity of resulting illness; and the medical or other measures available to control the impact of the virus (for example, vaccines or medications that can treat the illness). That this disease has caused severe illness, including illness resulting in death is concerning, especially since it has also shown sustained person-to-person spread in several places. These factors meet two of the criteria of a pandemic. As community spread is detected in more and more countries, the world moves closer toward meeting the third criteria, worldwide spread of the new virus.It is important to note that current circumstances suggest it is likely that this virus will cause a pandemic. This is a rapidly evolving situation and CDC’s risk assessment will be updated as needed.Current risk assessment:For the majority of people, the immediate risk of being exposed to the virus that causes COVID-19 is thought to be low. There is not widespread circulation in most communities in the United States.People in places where ongoing community spread of the virus that causes COVID-19 has been reported are at elevated risk of exposure, with increase in risk dependent on the location.Healthcare workers caring for patients with COVID-19 are at elevated risk of exposure.Close contacts of persons with COVID-19 also are at elevated risk of exposure.Travelers returning from affected international locations where community spread is occurring also are at elevated risk of exposure, with increase in risk dependent on location.CDC has developed guidance to help in the risk assessment and management of people with potential exposures to COVID-19.What May HappenMore cases of COVID-19 are likely to be identified in the United States in the coming days, including more instances of community spread. It’s likely that at some point, widespread transmission of COVID-19 in the United States will occur. Widespread transmission of COVID-19 would translate into large numbers of people needing medical care at the same time. Schools, childcare centers, and workplaces, may experience more absenteeism. Mass gatherings may be sparsely attended or postponed. Public health and healthcare systems may become overloaded, with elevated rates of hospitalizations and deaths. Other critical infrastructure, such as law enforcement, emergency medical services, and sectors of the transportation industry may also be affected. Healthcare providers and hospitals may be overwhelmed. At this time, there is no vaccine to protect against COVID-19 and no medications approved to treat it. Nonpharmaceutical interventions would be the most important response strategy.CDC ResponseGlobal efforts at this time are focused concurrently on lessening the spread and impact of this virus. The federal government is working closely with state, local, tribal, and territorial partners, as well as public health partners, to respond to this public health threat.CDC is implementing its pandemic preparedness and response plans, working on multiple fronts, including providing specific guidance on measures to prepare communities to respond to local spread of the virus that causes COVID-19. There is an abundance of pandemic guidance developed in anticipation of an influenza pandemic that is being adapted for a potential COVID-19 pandemic.Highlights of CDC’s ResponseCDC established a COVID-19 Incident Management System on January 7, 2020. On January 21, CDC activated its Emergency Operations Center to better provide ongoing support to the COVID-19 response.The U.S. government has taken unprecedented steps with respect to travel in response to the growing public health threat posed by this new coronavirus:Foreign nationals who have been in China or Iran within the past 14 days cannot enter the United States.U.S. citizens, residents, and their immediate family members who have been in China or Iran within in the past 14 days can enter the United States, but they are subject to health monitoring and possible quarantine for up to 14 days.On March 8, CDC recommended that people at higher risk of serious COVID-19 illness avoid cruise travel and non-essential air travel.Additionally, CDC has issued the following additional specific travel guidance related to COVID-19. View larger image and see a list of locations Twitter For people who are ill with COVID-19, but are not sick enough to be hospitalized, please follow CDC guidance on how to reduce the risk of spreading your illness to others. People who are mildly ill with COVID-19 are able to isolate at home during their illness.If you have been in China or another affected area or have been exposed to someone sick with COVID-19 in the last 14 days, you will face some limitations on your movement and activity. Please follow instructions during this time. Your cooperation is integral to the ongoing public health response to try to slow spread of this virus.Other Available ResourcesThe following resources are available with information on COVID-19World Health Organization, Coronavirus CoronavirusIndianaLocalMichiganNationalNewsSouth Bend Market Google+ Facebook Google+ WhatsApp Previous articleSt. Joseph County has identified its first positive coronavirus testNext articleCoronavirus has come to Michiana: Here’s what you need to know Tommie Leelast_img read more

Baruj Benacerraf, Nobel laureate, 90

first_imgBaruj Benacerraf, who earned a 1980 Nobel Prize in physiology or medicine for his groundbreaking research in immunology and led Dana-Farber Cancer Institute through a period of tremendous growth beginning that year, died in Boston on Aug. 2 at the age of 90.Benacerraf’s medical legacy is broad. As a physician-scientist, he discovered that genetic factors play a central role in the function of the immune system, a finding that paved the way for most of modern immunology and earned the Nobel Prize for him and colleagues Jean Dausset of the Université de Paris, and George D. Snell of Jackson Laboratory in Bar Harbor, Maine.As president of Dana-Farber, Benacerraf helped the institution expand both physically and scientifically. He recruited top researchers and clinicians from around the world to Dana-Farber’s Boston campus, where they could also serve as teaching professors at Harvard Medical School next door. He himself was chairman of the Department of Pathology and was the George Fabyan Professor of Comparative Pathology at Harvard Medical School from 1970 to 1991.As Dana-Farber’s international reputation grew, so did its physical footprint, with completion of the Louis B. Mayer Laboratories in 1988 and the Richard A. and Susan F. Smith Research Laboratories building nearly a decade later. Benacerraf led Dana-Farber through that expansion, tapping into his keen understanding of business, which he developed from his father, a successful financier and textile importer.Stepping down as president in 1992, he continued working daily in his own lab at Dana-Farber into his 80s, and hosted an annual symposium at which he delighted in chatting with the many former students and protégés who had become international leaders in the fight against cancer and related diseases.“Dr. Benacerraf’s seminal discoveries about genetic control of the immune system made possible much of what we now know about basic disease processes such as infection, autoimmune disorders, and cancer,” said Dana-Farber President Edward J. Benz Jr. “His work has shaped everything from organ transplantation, to AIDS treatment, to, most recently, the development of therapeutic cancer vaccines.”Benacerraf had an upbringing that helped shape him as a leader. Born in Caracas, Venezuela, in 1920, and raised in pre-World War II Paris, he came to the United States in 1939. He was educated first at Columbia University, and then at the Medical College of Virginia. After serving in the U.S. Army Medical Corps, he began a career in medical research. In his 1998 autobiography, “From Caracas to Stockholm: A Life In Medical Science,” he discussed the anti-Semitic quota systems and anti-foreigner bias he encountered in being rejected by 25 medical schools, including Harvard.In 1956 he went to New York University School of Medicine to work in cellular immunology, where his students included future Dana-Farber colleagues Steven Burakoff and Stuart Schlossman. Schlossman said it was Benacerraf’s ability to identify good people and bring them together that made him so successful as a leader.“He was extremely considerate of people, and had sensitivity for their needs,” said Schlossman, the Baruj Benacerraf Professor of Medicine at Harvard Medical School. “He created an environment where everybody could prosper, and young people could develop wonderful careers of their own. The scientific health of our community was supported tremendously by Dr. Benacerraf.”His late wife, Annette Dreyfus, who died on June 3, was the niece of another Nobel laureate (Jacques Lucien Monod) and was almost always by Benacerraf’s side at symposia and other events in recent years. Their only child, Beryl Benacerraf, is a radiologist at Brigham and Women’s Hospital, a clinical professor of radiology and obstetrics, gynecology, and reproductive biology at Harvard Medical School, and the president and founder at Diagnostic Ultrasound Associates.In addition to his daughter, he is survived by his brother Paul Benacerraf, who is the James S. McDonnell Distinguished University Professor of Philosophy emeritus at Princeton University and former provost at Princeton (1988-91), and two grandchildren, Brigitte Libby of Chestnut Hill, and Oliver Libby of New York City.“Baruj Benacerraf was a congenital leader,” said Dana-Farber President Emeritus David G. Nathan. “He combined scientific insight, brilliant management skills, no-nonsense tolerance, fierce loyalty, and remarkable vision. Dana-Farber achieved widely accepted prominence under his guidance. We are deeply grateful to his memory and to his late wife, daughter, and grandchildren, who shared so much of him with us.”last_img read more

U.S. is becoming world’s new tax haven

first_imgThe U.S. was expected to reciprocate, by sharing data on the accounts of foreign taxpayers with their respective governments.Yet Congress rejected the Obama administration’s repeated requests to make the necessary changes to the tax code.As a result, the Treasury cannot compel U.S. banks to reveal information such as account balances and names of beneficial owners.The U.S. has also failed to adopt the so-called Common Reporting Standard, a global agreement under which more than 100 countries will automatically provide each other with even more data than FATCA requires.While the rest of the world provides the transparency that the U.S. demanded, the U.S. is rapidly becoming the new Switzerland.Financial institutions catering to the global elite, such as Rothschild & Co. and Trident Trust Co., have moved accounts from offshore havens to Nevada, Wyoming and South Dakota.New York lawyers are actively marketing the country as a place to park assets. A Russian billionaire, for example, can put real-estate assets in a U.S. trust and rest assured that neither the U.S. tax authorities nor his home-country government will know anything about it.That’s a level of secrecy that not even Vanuatu can offer.From a certain perspective, all this might look pretty smart: Shut down foreign tax havens and then steal their business. That would be the kind of thinking that’s undermining America’s standing in so many areas, from trade to climate change.Instead of using its power to establish an equitable system of global governance, it’s demanding a standard from the rest of the world that it refuses to apply to itself.That isn’t leadership.More from The Daily Gazette:EDITORIAL: Urgent: Today is the last day to complete the censusEDITORIAL: Beware of voter intimidationEDITORIAL: Thruway tax unfair to working motoristsEDITORIAL: Find a way to get family members into nursing homesFoss: Should main downtown branch of the Schenectady County Public Library reopen? Seven years ago, the U.S. led an effort to address a problem facing governments everywhere.Each year, people manage to avoid paying an estimated $2.5 trillion in income tax — a giant sum that could be used to combat poverty, update infrastructure or lower tax rates for law-abiding citizens.Now, however, the U.S. is becoming one of the world’s best places to hide money from the tax collector. It’s a distinction the country would do well to shed.In 2009, amid growing budget deficits and a tax-fraud scandal at Swiss bank UBS AG, the Group of 20 developed and developing nations came to an agreement:They would no longer tolerate the network of havens, shell companies and secret accounts that had long abetted tax evasion.A year later, the U.S. passed the Foreign Account Tax Compliance Act, which required foreign financial institutions to report the identities and assets of potential U.S. taxpayers to the Internal Revenue Service.Under threat of losing access to the U.S. financial system, more than 100 countries — including such traditional havens as Bermuda and the Cayman Islands — are complying or have agreed to comply.center_img Categories: Editorial, OpinionThe following editorial appears on Bloomberg View:last_img read more